生殖医学杂志2026,Vol.35Issue(10):1250-1259,10.DOI:10.3969/j.issn.1004-3845.2026.10.007
拮抗剂方案鲜胚移植添加GnRH-a强化黄体支持对不同卵巢反应人群妊娠结局影响的研究
Effects of enhanced luteal support with additional GnRH agonist on pregnancy outcomes among patients with distinct ovarian responses undergoing fresh embryo transfer cycles in antagonist protocol
摘要
Abstract
Objectives:To explore the effects of additional gonadotropin-releasing hormone agonist(GnRH-a)supplementation on the basis of conventional luteal support on pregnancy outcomes in patients with different ovarian responses undergoing fresh embryo transfer with GnRH antagonist protocol. Methods:A retrospective cohort study was conducted,including clinical data of 950 patients who underwent controlled ovarian stimulation with the GnRH antagonist protocol and fresh embryo transfer at the Reproductive Center of the First Hospital of Lanzhou University from June 2023 to December 2024.Patients were divided into conventional luteal support group(558 cases,with progesterone plus dydrogesterone support)and GnRH-a addition group(392 cases,receiving 0.1 mg triptorelin on days 6,9 and 12 after oocyte retrieval besides conventional support)according to whether GnRH-a was supplemented in luteal support.Inverse probability treatment weighting(IPTW)by propensity score was used to balance baseline confounding factors.Weighted regression models were applied to evaluate the overall effect of additional GnRH-a on pregnancy outcomes.Patients were further stratified into poor ovarian response(POR),normal ovarian response(NOR)and high ovarian response(HOR)subgroups.Interaction terms were introduced into regression models to assess the treatment effect of supplementary GnRH-a under different ovarian response statuses and explore effect heterogeneity. Results:After IPTW weighting,baseline characteristics were well balanced between the two groups(P>0.05).Overall analysis demonstrated that,compared with the conventional luteal support group,the GnRH-a addition group achieved significantly higher clinical pregnancy rate[(42.3%vs.34.8%),OR=1.37,95%CI(1.01,1.86),P=0.041]and live birth rate[(38.8%vs.28.1%),OR=1.61,95%CI(1.22,2.13),P<0.001].Moreover,GnRHa addition significantly reduced the early miscarriage rate[(6.6%vs.12.9%),OR=0.48,95%CI(0.23,0.99),P=0.047]and ectopic pregnancy rate[(1.8%vs.6.2%),OR=0.29,95%CI(0.08,0.99),P=0.049].No significant differences were found in positive HCG rate and twin pregnancy rate between groups(P>0.05).Subgroup analyses revealed that GnRH-a addition significantly elevated positive HCG rate[OR=1.43,95%CI(1.18,1.73),P<0.001]and clinical pregnancy rate[OR=1.64,95%CI(1.35,1.99),P<0.001]in NOR patients.In POR patients,additional GnRH-a exerted no significant influence on all pregnancy outcomes(P>0.05),although there seemed to be a trend toward a reduced risk of twin pregnancy[OR=0.39,95%CI(0.11,1.36),P=0.137].For HOR patients,GnRH-a addition showed a potential protective tendency against early miscarriage[OR=0.41,95%CI(0.16,1.05),P=0.063];however,regarding HCG positivity rate[OR=0.69,95%CI(0.54,0.89),P=0.004]and clinical pregnancy rate[OR=0.62,95%CI(0.48,0.79),P<0.001],there were significant negative interactions with the NOR group(interaction P<0.001),indicating that the clinical benefit of this treatment was significantly attenuated in the HOR population. Conclusions:Intermittent subcutaneous injection of GnRHa on days 6,9,and 12 after oocyte retrieval as an addition to conventional luteal support could improve overall live birth rate and clinical pregnancy rate,and lower risks of early miscarriage and ectopic pregnancy in fresh embryo transfer cycles with GnRH antagonist protocol.Distinct clinical benefits of this treatment were observed specifically in NOR patients,without obvious adverse impacts on POR patients,but caution should be exercised when evaluating the applicability of this treatment in HOR patients.关键词
体外受精-胚胎移植/促性腺激素释放激素激动剂/黄体支持/临床结局Key words
In vitro fertilization and embryo transfer/Gonadotropin-releasing hormone agonist/Luteal support/Clinical outcomes分类
医药卫生引用本文复制引用
张雅冰,杜乐凡,吉亭亭,刘娇,马晓玲..拮抗剂方案鲜胚移植添加GnRH-a强化黄体支持对不同卵巢反应人群妊娠结局影响的研究[J].生殖医学杂志,2026,35(10):1250-1259,10.基金项目
甘肃省科技计划(21JR7RA391) (21JR7RA391)
兰州市科技计划项目(2025-2-26) (2025-2-26)